Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 44, Issue 12 (Dec 2006)

Issues

Blood transfusions in athletes. Old dogmas, new tricks

Giuseppe Lippi
  • Sezione di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Università degli Studi di Verona, Verona, Italy and Gruppo di Studio della Società Italiana di Biochimica Clinica (SIBioC) per la Medicina di Laboratorio dello Sport, Milan, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Giuseppe Banfi
  • Istituto Galeazzi and University of Milan, Milano, Italy and Gruppo di Studio della Società Italiana di Biochimica Clinica (SIBioC) per la Medicina di Laboratorio dello Sport, Milan, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2006-12-13 | DOI: https://doi.org/10.1515/CCLM.2006.262

Abstract

Blood doping consists of any illicit means used to increase and optimize oxygen delivery to the muscles and includes blood transfusions, administration of erythropoiesis-stimulating substances, blood substitutes, natural or artificial altitude facilities, and innovative gene therapies. The use of blood transfusion, an extremely straightforward, practical and effective means of increasing an athlete's red blood-cell supply in advance of competition, became rather popular in the 1970s, but it has suddenly declined following the widespread use of recombinant human erythropoietin among elite endurance athletes. Most recently, following implementation of reliable tests to screen for erythropoiesis-stimulating substances, blood transfusions have made a strong resurgence, as attested by several positive doping tests. Doping by blood transfusion can be classified as homologous, where the blood is infused into someone other than the donor, and autologous, where the blood donor and transfusion recipient are the same. The former case produces more clinically relevant side effects, but is easily detectable using current antidoping protocols based on erythrocyte phenotyping by flow cytometry and, eventually, erythrocyte genotyping by DNA testing. Since the donor and recipient blood are identical in autologous blood doping, this is less risky, though much more challenging to detect. Indirect strategies, relying on significant deviations from individual hematological profiles following autologous blood donation and reinfusion, are currently being investigated. For the time being, the storage of athletes' blood samples to allow testing and sanctioning of guilty athletes once a definitive test has been introduced may represent a reliable deterrent policy.

Clin Chem Lab Med 2006;44:1395–402.

Keywords: antidoping testing; blood doping; blood transfusion; hemoglobin; sports

References

  • 1.

    Prendergast HM, Bannen T, Erickson TB, Honore KR. The toxic torch of the modern Olympic Games. Vet Hum Toxicol 2003; 45:97–102.Google Scholar

  • 2.

    Lippi G, Franchini M, Salvagno GL, Guidi GC. Biochemistry, physiology, and complications of blood doping: facts and speculation. Crit Rev Clin Lab Sci 2006; 43:349–91.CrossrefGoogle Scholar

  • 3.

    Williams MH, Wesseldine S, Somma T, Schuster R. The effect of induced erythrocythemia upon 5-mile treadmill run time. Med Sci Sports Exerc 1981; 13:169–75.CrossrefGoogle Scholar

  • 4.

    Brien AJ, Simon TL. The effects of red blood cell infusion on 10-km race time. J Am Med Assoc 1987; 257:2761–5.CrossrefGoogle Scholar

  • 5.

    Robertson RJ, Gilcher R, Metz KF, Skrinar GS, Allison TG, Bahnson HT, et al. Effect of induced erythrocythemia on hypoxia tolerance during exercise. J Appl Physiol 1982; 53:490–5.Google Scholar

  • 6.

    Buick FJ, Gledhill N, Froese AB, Spriet L, Meyers EC. Effect of induced erythrocythemia on aerobic work capacity. J Appl Physiol 1980; 48:636–42.Google Scholar

  • 7.

    Ekblom BT. Blood boosting and sport. Baillieres Best Pract Res Clin Endocrinol Metab 2000; 14:89–98.CrossrefGoogle Scholar

  • 8.

    Berglund B, Hemmingson P. Effect of reinfusion of autologous blood on exercise performance in cross-country skiers. Int J Sports Med 1987; 8:231–3.CrossrefGoogle Scholar

  • 9.

    Spriet LL, Gledhill N, Froese AB, Wilkes DL. Effect of graded erythrocythemia on cardiovascular and metabolic responses to exercise. J Appl Physiol 1986; 61:1942–8.Google Scholar

  • 10.

    Jones M, Tunstall Pedoe D. Blood doping: a literature review. Br J Sports Med 1989; 23:84–8.CrossrefGoogle Scholar

  • 11.

    Leigh-Smith S. Blood boosting. Br J Sports Med 2004; 38:99–101.CrossrefGoogle Scholar

  • 12.

    McCrory P. Pursuing the dream. Br J Sports Med 2004; 38:665.CrossrefGoogle Scholar

  • 13.

    Ekblom B, Goldbarg AN, Gullbring B. Response to exercise after blood loss and reinfusion. J Appl Physiol 1972; 33:175–80.Google Scholar

  • 14.

    Klein HG. Blood transfusion and athletic games people play. N Engl J Med 1985; 312:854–6.CrossrefGoogle Scholar

  • 15.

    Spivak JL. Erythropoietin use and abuse: when physiology and pharmacology collide. Adv Exp Med Biol 2001; 502:207–24.CrossrefGoogle Scholar

  • 16.

    Stray-Gundersen J, Videman T, Penttila I, Lereim I. Abnormal hematologic profiles in elite cross-country skiers: blood doping or? Clin J Sport Med 2003; 13:132–7.CrossrefGoogle Scholar

  • 17.

    D'Onofrio G, Zini G. Addendum to strategies to deter blood doping in sports. Haematologica 2002; 87:ELT31.Google Scholar

  • 18.

    Abellan R, Remacha AF, Ventura R, Sardà MP, Segura J, Rodriguez FA. Hematologic response to four weeks of intermittent hypobaric hypoxia in highly trained athletes. Haematologica 2005; 90:126–7.Google Scholar

  • 19.

    Rice L, Alfrey CP. The negative regulation of red cell mass by neocytolysis: physiologic and pathophysiologic manifestations. Cell Physiol Biochem 2005; 15:245–50.CrossrefGoogle Scholar

  • 20.

    Berglund B, Girgegard G, Wide L, Philstedt P. Effects of blood transfusion on some haematological variables in endurance athletes, Med Sci Sports Exerc 1989; 21:637–42.CrossrefGoogle Scholar

  • 21.

    Union Cycliste International. Puerto operation: The UCI's standpoint. Available at http://www.uci.ch/. Accessed 2 August 2006.Google Scholar

  • 22.

    USA Today. Spanish scandal not limited to cycling. Available at http://www.usatoday.com. Accessed 2 August 2006.Google Scholar

  • 23.

    Haisma HJ, de Hon O. Gene doping. Int J Sports Med 2006; 27:257–66.CrossrefGoogle Scholar

  • 24.

    Robinson N, Giraud S, Saudan C, Baume N, Avois L, Mangin P, et al. Erythropoietin and blood doping. Br J Sports Med 2006; 40(Suppl 1):30–4.CrossrefGoogle Scholar

  • 25.

    Parisotto R, Gore CJ, Emslie KR, Ashenden MJ, Brugnara C, Howe C, et al. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. Haematologica 2000; 85:564–72.Google Scholar

  • 26.

    Cartron JP. Defining the Rh blood group antigens. Biochemistry and molecular genetics. Blood Rev 1994; 8:199–212.CrossrefGoogle Scholar

  • 27.

    Nelson M, Ashenden M, Langshaw M, Popp H. Detection of homologous blood transfusion by flow cytometry: a deterrent against blood doping. Haematologica 2002; 87:881–2.Google Scholar

  • 28.

    Nelson M, Popp H, Sharpe K, Ashenden M. Proof of homologous blood transfusion through quantification of blood group antigens. Haematologica 2003; 88:1284–95.Google Scholar

  • 29.

    Wu YY, Csako G. Rapid and/or high-throughput genotyping for human red blood cell, platelet and leukocyte antigens, and forensic applications. Clin Chim Acta 2006; 363:165–76.CrossrefGoogle Scholar

  • 30.

    Drexler C, Glock B, Vadon M, Staudacher E, Dauber EM, Ulrich S, et al. Tetragametic chimerism detected in a healthy woman with mixed-field agglutination reactions in ABO blood grouping. Transfusion 2005; 45:698–703.CrossrefGoogle Scholar

  • 31.

    Avent ND, Reid ME. The Rh blood group system: a review. Blood 2000; 95:375–87.Google Scholar

  • 32.

    Flegel WA, Wagner FF, Müller TH, Gassner C. Rh phenotype prediction by DNA typing and its application to practice. Transfus Med 1998; 8:281–302.CrossrefGoogle Scholar

  • 33.

    Montpetit A, Phillips MS, Mongrain I, Lemieux R, St-Louis M. High-throughput molecular profiling of blood donors for minor red blood cell and platelet antigens. Transfusion 2006; 46:841–8.CrossrefGoogle Scholar

  • 34.

    Beiboer SH, Wieringa-Jelsma T, Maaskant-Van Wijk PA, van der Schoot CE, van Zwieten R, Roos D, et al. Rapid genotyping of blood group antigens by multiplex polymerase chain reaction and DNA microarray hybridization. Transfusion 2005; 45:667–79.CrossrefGoogle Scholar

  • 35.

    Denomme GA, Van Oene M. High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes. Transfusion 2005; 45:660–6.CrossrefGoogle Scholar

  • 36.

    Hashmi G, Shariff T, Seul M, Vissavajjhala P, Hue-Roye K, Charles-Pierre D, et al. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion 2005; 45:680–8.CrossrefGoogle Scholar

  • 37.

    Pellegrino J Jr, Castilho L, Rios M, De Souza CA. Blood group genotyping in a population of highly diverse ancestry. J Clin Lab Anal 2001; 15:8–13.CrossrefGoogle Scholar

  • 38.

    Smith KJ, James DS, Hunt WC, McDonough W, Quintana R. A randomized, double-blind comparison of donor tolerance of 400 mL, 200 mL, and sham red cell donation. Transfusion 1996; 36:674–80.CrossrefGoogle Scholar

  • 39.

    Starklint J, Norgaard Bech J, Aagaard O, Bjerregaard Pedersen E. Hypochromic reticulocytes, hypochromic erythrocytes and p-transferrin receptors in diagnosing iron-deficient erythropoiesis. Scand J Clin Lab Invest 2004; 64:691–702.CrossrefGoogle Scholar

  • 40.

    Damsgaard R, Munch T, Morkeberg J, Mortensen SP, Gonzalez-Alonso J. Effects of blood withdrawal and reinfusion on biomarkers of erythropoiesis in humans: implications for anti-doping strategies. Haematologica 2006; 91:1006–8.Google Scholar

  • 41.

    Berglund B, Hemmingsson P, Birgegard G. Detection of autologous blood transfusions in cross-country skiers. Int J Sports Med 1987; 8:66–70.CrossrefGoogle Scholar

  • 42.

    Guidi GC, Lippi G, Solero GP, Poli G, Plebani M. Managing transferability of laboratory data. Clin Chim Acta 2006. In press; doi:10.1016/j.cca.2006.06.009.CrossrefGoogle Scholar

  • 43.

    Fraser CG, Wilkinson SP, Neville RG, Knox JD, King JF, Mac Walter RS. Biologic variation of common hematologic laboratory quantities in the elderly. Am J Clin Pathol 1989; 92:464–70.CrossrefGoogle Scholar

  • 44.

    Banfi G, Mauri C, Morelli B, Di Gaetano N, Malgeri U, Melegati G. Reticulocyte count, mean reticulocyte volume, immature reticulocyte fraction, and mean sphered cell volume in elite athletes: reference values and comparison with the general population. Clin Chem Lab Med 2006; 44:616–22.CrossrefGoogle Scholar

  • 45.

    Malcovati L, Pascutto C, Cazzola M. Hematologic passport for athletes competing in endurance sports: a feasibility study. Haematologica 2003; 88:570–1.Google Scholar

  • 46.

    Ashenden MJ, Lacoste A, Orhant E, Audran M, Sharpe K. Longitudinal variation of hemoglobin and reticulocytes in elite rowers. Haematologica 2004; 89:1403–4.Google Scholar

  • 47.

    Sharpe K, Ashenden MJ, Schumacher YO. A third generation approach to detect erythropoietin abuse in athletes. Haematologica 2006; 91:356–63.Google Scholar

  • 48.

    Ashenden MJ, Sharpe K, Schoch C, Schumacher YO. Effect of pre-competition and altitude training on blood models used to detect erythropoietin abuse by athletes. Haematologica 2004; 89:1019–20.Google Scholar

  • 49.

    Ekblom B, Holmberg HC, Eriksson K. Doping in endurance sports. Survey of individual [Hb] levels can expose doping. Lakartidningen 2001; 98:5490–2.Google Scholar

  • 50.

    Banfi G, Dolci A, Zorzino L, Longhi E, Barberis M. Comparison of 3 automatic systems for reticulocytes counts during an ultraendurance mountain marathon. J Sports Med Phys Fitness 2003; 43:256–7.Google Scholar

  • 51.

    Ashenden MJ, Sharpe K, Damsgaard R, Jarvis L. Standardization of reticulocyte values in an antidoping context. Am J Clin Pathol 2004; 121:816–25.CrossrefGoogle Scholar

  • 52.

    Costongs GM, Janson PC, Bas BM, Hermans J, Brombacher PJ, Van Wersch JW. Short-term and long-term intraindividual variations and critical difference of haematological laboratory parameters. J Clin Chem Clin Biochem 1985; 23:69–76.Google Scholar

  • 53.

    Schumacher YO, Jankovits R, Bultermann D, Schmid A, Berg A. Hematological indices in elite cyclists. Scand J Med Sci Sports 2002; 12:301–8.CrossrefGoogle Scholar

  • 54.

    Schumacher YO, Grathwohl D, Barturen JM, Wollenweber M, Heinrich L, Schmid A, et al. Haemoglobin, haematocrit and red blood cell indices in elite cyclists. Are the control values for blood testing valid? Int J Sports Med 2000; 21:380–5.CrossrefGoogle Scholar

  • 55.

    Lippi G, Franchini M, Guidi G. Haematocrit measurement and antidoping policies. Clin Lab Haematol 2002; 24:65–6.CrossrefGoogle Scholar

  • 56.

    Banfi G, Del Fabbro M, Mauri C, Corsi MM, Melegati G. Haematological parameters in elite rugby players during a competitive season. Clin Lab Haematol 2006; 28:183–8.CrossrefGoogle Scholar

  • 57.

    Lippi G, Guidi GC, Mattiuzzi C, Plebani M. Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med 2006; 44:358–65.CrossrefGoogle Scholar

  • 58.

    Lippi G, Salvagno GL, Montagnana M, Franchini M, Guidi GC. Phlebotomy issues and quality improvement in results of laboratory testing. Clin Lab 2006; 52:217–30.Google Scholar

  • 59.

    Banfi G, Dolci A. Preanalytical phase of sport biochemistry and haematology. J Sports Med Phys Fitness 2003; 43:223–30.Google Scholar

  • 60.

    Lippi G, Franchini M, Guidi GC. Haematological testing and antidoping policies. Int J Sports Med 2005; 26:508–9.CrossrefGoogle Scholar

  • 61.

    Lippi G, Salvagno GL, Solero GP, Franchini M, Guidi GC. Stability of blood cell counts, hematologic parameters and reticulocytes indexes on the Advia A120 hematologic analyzer. J Lab Clin Med 2005; 146:333–40.CrossrefGoogle Scholar

  • 62.

    Lippi G, Salvagno GL, Solero GP, Guidi GC. The influence of the tourniquet time on hematological testing for antidoping purposes. Int J Sports Med 2006; 27:359–62.CrossrefGoogle Scholar

  • 63.

    Sandler SG, Yu H, Rassai N. Risks of blood transfusion and their prevention. Clin Adv Hematol Oncol 2003; 1:307–13.Google Scholar

  • 64.

    Ghaphery NA. Performance-enhancing drugs. Orthop Clin North Am 1995; 26:433–42.PubMedGoogle Scholar

  • 65.

    Smith DA, Perry PJ. The efficacy of ergogenic agents in athletic competition. Part II. Other performance-enhancing agents. Ann Pharmacother 1992; 26:653–9.CrossrefGoogle Scholar

  • 66.

    Gauthier J. Blood doping and cardiovascular consequences. Presse Med 2002; 31:1904–8.Google Scholar

  • 67.

    Lippi G, Franchini M, Guidi G. Second generation blood tests to detect erythropoietin abuse by athletes: effective but not preventive? Haematologica 2004; 89:ELT05.Google Scholar

About the article

Corresponding author: Prof. Giuseppe Lippi, Sezione di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Università degli Studi di Verona, Ospedale Policlinico G.B. Rossi, Piazzale Scuro, 10, 37134 Verona, Italy Fax: +39-045-8201889


Received: 2006-08-03

Accepted: 2006-08-28

Published Online: 2006-12-13

Published in Print: 2006-12-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2006.262.

Export Citation

©2006 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Elliott Bennett-Guerrero, Evelyn L. Lockhart, Nicholas Bandarenko, Mary L. Campbell, Michael J. Natoli, Veronika K. Jamnik, Timothy R. Carter, and Richard E. Moon
Transfusion, 2017, Volume 57, Number 3, Page 630
[2]
Olivier Salamin, Sara De Angelis, Jean-Daniel Tissot, Martial Saugy, and Nicolas Leuenberger
Transfusion Medicine Reviews, 2016, Volume 30, Number 3, Page 109
[3]
Giuseppe Lippi, Camilla Mattiuzzi, and Fabian Sanchis-Gomar
Performance Enhancement & Health, 2014, Volume 3, Number 1, Page 45
[4]
Steve Elliott and Barbara Leishman
Bioanalysis, 2012, Volume 4, Number 13, Page 1681
[5]
Angela J. Schneider, Matthew N. Fedoruk, and Jim L. Rupert
Journal of Sports Sciences, 2012, Volume 30, Number 11, Page 1117
[6]
Giuseppe Lippi, Giuseppe Banfi, Massimo Franchini, and Gian Cesare Guidi
Journal of Sports Sciences, 2008, Volume 26, Number 5, Page 441
[7]
R.J. Shephard
Yearbook of Sports Medicine, 2008, Volume 2008, Page 169
[8]
Michael A. Short, Carol K. Clark, John W. Harvey, Nanny Wenzlow, Ian K. Hawkins, David R. Allred, Donald P. Knowles, Joseph L. Corn, Juanita F. Grause, Steven G. Hennager, Diane L. Kitchen, and Josie L. Traub-Dargatz
Journal of the American Veterinary Medical Association, 2012, Volume 240, Number 5, Page 588
[9]
Jakob Mørkeberg
Transfusion Medicine Reviews, 2012, Volume 26, Number 3, Page 199
[10]
Giuseppe Banfi
Clinical Chemistry and Laboratory Medicine, 2011, Volume 49, Number 9
[11]
Giuseppe Lippi and Mario Plebani
Clinical Chemistry and Laboratory Medicine, 2011, Volume 49, Number 9
[13]
J. Mørkeberg, K. Sharpe, B. Belhage, R. Damsgaard, W. Schmidt, N. Prommer, C. J. Gore, and M. J. Ashenden
Scandinavian Journal of Medicine & Science in Sports, 2011, Volume 21, Number 2, Page 235
[14]
Giuseppe Lippi, Giuseppe Banfi, Gian Luca Salvagno, Martina Montagnana, Massimo Franchini, and Gian Cesare Guidi
Clinical Chemical Laboratory Medicine, 2008, Volume 46, Number 2
[15]
Giuseppe Lippi and Massimo Franchini
European Journal of Applied Physiology, 2010, Volume 108, Number 2, Page 411
[16]
Patricia A. Arndt and Belinda M. Kumpel
American Journal of Hematology, 2008, Volume 83, Number 8, Page 657

Comments (0)

Please log in or register to comment.
Log in